Boston, MA, May 10, 2014 --(PR.com
)-- Philippe Lopes-Fernandes, Senior Vice President of Global Licensing, Business Development & Alliance Management at Merck Serono, will give a keynote presentation at the 3rd Oncology Partnering & Deal-Making Conference to be held on July 7-8, 2014, in Boston, MA.
Philippe is responsible for developing search strategies, conducting the search and evaluation of partnering, licensing and M&A opportunities and managing the established alliances. His team provides end-to-end transactions support to ensure execution of high-quality global deals for all Merck Serono business units and all stages of development from early technology to clinical stage and marketed products.
GTCBio's 3rd Oncology Partnering & Deal-Making Conference is a partnership and business development conference that provides an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies as well as explore potential collaborations and learn about relevant issues in oncology that will affect the industry. Experts in the field of oncology will present on the latest discoveries, novel technologies, business development trends, markets, partnership opportunities, alliance management, value maximization vs. capital efficiency and IPOs. There will be a mix of presentations and interactive panel discussions so join your business development colleagues at this unique partnering forum!
This conference is part of the larger Novel Cancer Therapeutics Summit, which consists of two co-located parallel conferences:
3rd Oncology Partnering & Deal-Making Conference
5th Cancer Targets & Therapeutics Conference
For more information, please visit www.gtcbio.com